Department of Cardiology, 5th Center of Chinese PLA General Hospital, Beijing 100071, China.
Department of Respiratory and Critical Care Diseases, 5th Center of Chinese PLA General Hospital, Beijing 100071, China.
Int Immunopharmacol. 2020 Dec;89(Pt A):107031. doi: 10.1016/j.intimp.2020.107031. Epub 2020 Sep 23.
Clearance of COVID-19 from the human body has not been established. Our study collected the laboratory test results from patients and analyzed the correlation between early changes in serum indices and the virus clearance by univariable and multivariable COX regression models, with an aim to explore the risk factors for prolonged viral clearance. The study included 61 patients with COVID-19 treated at the Fifth Medical Center of PLA General Hospital in Beijing from 20 January 2020 to 20 February 2020. We set the total observation of the disease course to 20 days and the patients were divided into two groups (prolonged group, > 20d vs. normal group, ≤ 20d). The 48 patients with COVID-19 included in this study, 13 remained positive for viral nucleic acid monitoring 20 days after onset. The median for virus clearance was 16 days (range, 6-35 days). The results showed that hypertension, a lactate dehydrogenase level > 211.5 U/L, an interleukin 6 (IL-6) level > 12.5 pg/ml, and a NK lymphocyte percentage > 0.5% were associated with prolonged viral clearance. Therefore, we showed that a history of hypertension, an elevated IL-6 level, and an elevated percentage of NK cells were risk factors for prolonged viral clearance.
尚未确定 COVID-19 从人体中的清除情况。我们的研究收集了患者的实验室检测结果,并通过单变量和多变量 COX 回归模型分析了血清指标早期变化与病毒清除之间的相关性,旨在探讨延长病毒清除时间的危险因素。该研究纳入了 2020 年 1 月 20 日至 2 月 20 日期间在北京解放军总医院第五医疗中心治疗的 61 例 COVID-19 患者。我们将疾病总观察期设定为 20 天,并将患者分为两组(延长组,>20d 与正常组,≤20d)。本研究中纳入的 48 例 COVID-19 患者中,有 13 例在发病后 20 天仍监测到病毒核酸阳性。病毒清除的中位数为 16 天(范围,6-35 天)。结果表明,高血压、乳酸脱氢酶水平>211.5 U/L、白细胞介素 6(IL-6)水平>12.5 pg/ml 和 NK 淋巴细胞百分比>0.5%与延长病毒清除有关。因此,我们表明高血压病史、IL-6 水平升高和 NK 细胞百分比升高是延长病毒清除时间的危险因素。